ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NAMSW NewAmsterdam Pharma Company NV

13.30
-0.29 (-2.13%)
16 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)
Total Revenue 2.94M803k1.4M2.28M29.11M
Operating Income -49.56M-50.79M-55.48M-52.58M-25M
Pre Tax Income -47.13M-49.47M-93.77M-39.01M-16.65M
Net Income -47.13M-49.5M-93.77M-39.01M-16.65M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) 00000
EBIT -49.56M-50.79M-55.48M-52.58M-25M
EBITDA -49.54M-50.78M-55.47M-52.56M-24.98M
Year End 31 December 2023 2023
USD (US$)
Total Revenue 14.09M
Operating Income -182.69M
Pre Tax Income -176.91M
Net Income -176.94M
Preferred Dividends 0
Basic Earnings Per Share (EPS) -2.145
EBIT -182.69M
EBITDA -182.64M

Your Recent History

Delayed Upgrade Clock